Corpus ID: 12769103

ANTIMICROBIAL RESISTANCE IN G7 COUNTRIES AND BEYOND: Economic Issues, Policies and Options for Action

@inproceedings{Cecchini2015ANTIMICROBIALRI,
  title={ANTIMICROBIAL RESISTANCE IN G7 COUNTRIES AND BEYOND: Economic Issues, Policies and Options for Action},
  author={Michele Cecchini and Juliane Langer and Luke Slawomirski},
  year={2015}
}
Solid and solution properties of the antimicrobial agent clofazimine
.............................................................................................................................................. VIII PUBLICATIONSExpand
A One Health Framework to Estimate Costs of Antimicrobial Resistance
Objectives/PurposeThe costs attributable to antimicrobial resistance (AMR) across human, animal, and environmental health remain theoretical and largely unspecified. Current figures fail to captureExpand
A Review on Antistaphylococcal Secondary Metabolites from Basidiomycetes
TLDR
An overview of findings from various studies on antibacterial secondary metabolites from basidiomycetes, with a special focus on antistaphylococcal activity is provided. Expand
Polish River Basins and Lakes – Part II: Biological Status and Water Management
This study presents the results of a long-term study of periphyton inhabiting submerged parts of shoots of Phragites australis, carried out in the ecosystems of northern Poland (lakes, rivers, oxbowsExpand
Socioeconomic Factors and Use of Antibiotics by Dairy Farmers vis-a-vis Antibiotic Resistance
TLDR
An updated preclinical paradigm is needed to assess the risk of resistance development in early preclinical development and is feasible and is not limited by methodology but rather by tradition. Expand
Activity of metabolites produced by new strains of Lactobacillus in modified de Man, Rogosa and Sharpe (MRS) medium against multidrug-resistant bacteria
TLDR
The activity of metabolites produced by new strains of Lactobacillus against multidrug-resistant bacteria was investigated and organic acids and ethanol are likely to be responsible for this antimicrobial activity. Expand
Delinking Investment in Antibiotic Research and Development from Sales Revenues: The Challenges of Transforming a Promising Idea into Reality
TLDR
Kevin Outterson and colleagues outline a model to address access, conservation, and innovation of antibiotics and suggest a three-pronged approach to achieve this goal. Expand
A General Public Study on Preferences and Welfare Impacts of Antimicrobial Resistance in the United Kingdom
TLDR
The aggregate annual willingness to pay for containing antimicrobial resistance was approximately £8.35 billion (~£5–£10 billion) and suggests that large investments in policies or interventions to combat antimicrobial Resistance are justified. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 121 REFERENCES
Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis.
TLDR
A meta-analysis was performed to summarize the impact of methicillin-resistance on mortality in Staphylococcus aureus bacteremia and explored the reasons for heterogeneity by means of subgroup analyses. Expand
Creating an intergovernmental consortium for new antibiotics: a new development
  • drugs”, Health Affairs (Millwood),
  • 2015
The impact of pricing and patent expiration on demand for pharmaceuticals: an examination of the use of broad-spectrum antimicrobials
  • K. Kaier
  • Medicine, Economics
  • Health Economics, Policy and Law
  • 2012
TLDR
It is concluded that price dependence of demand for antimicrobials is present both in the ambulatory and the hospital setting, however, this is especially surprising in the hospitalSetting because price differences among the antibiotics observed are particularly small compared with the overall cost of hospitalisation. Expand
Mortality and delay in effective therapy associated with extended-spectrum beta-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis.
TLDR
In Enterobacteriaceae bacteraemia, ESBL production is associated with increased mortality and delay in effective therapy, however, lack of controlled studies limits interpretation regarding causality, and further controlled studies are required. Expand
A new antibiotic kills pathogens without detectable resistance
TLDR
The properties of this compound suggest a path towards developing antibiotics that are likely to avoid development of resistance, as well as several methods to grow uncultured organisms by cultivation in situ or by using specific growth factors. Expand
Antibiotic innovation: some lessons from the WHO processes on public health, innovation and intellectual property
  • AMR Control,
  • 2015
Business Model Options for Antibiotics: Learning from Other Industries
As resistance to antibiotics continues to grow, there is a well-recognized misalignment between the clinical need for new antibiotics and the incentives for their development. The returns fromExpand
Comparative efficacy of interventions to promote hand hygiene in hospital: systematic review and network meta-analysis
TLDR
Network meta-analysis indicated considerable uncertainty in the relative effectiveness of interventions, but nonetheless provided evidence that WHO-5 is effective and that compliance can be further improved by adding interventions including goal setting, reward incentives, and accountability. Expand
...
1
2
3
4
5
...